Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07387796
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:41:25.496174+00:00
Published At
2026-04-27T00:00:00+00:00
Record Updated At
2026-04-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Drug Discontinuation", "Substance Use Disorders", "Eating Behavior Changes", "Tirzepatide"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-27"
protocolSection.identificationModule.nctId
"NCT07387796"
protocolSection.identificationModule.officialTitle
"Clinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Drug Discontinuation (protocolSection.conditionsModule.conditions)
  • Substance Use Disorders (protocolSection.conditionsModule.conditions)
  • Eating Behavior Changes (protocolSection.conditionsModule.conditions)
  • Tirzepatide (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.